Haleon PLC Logo

Haleon PLC

ISIN: GB00BMX86B70 | Ticker: HLN | LEI: 549300PSB3WWEODCUP19
Sector: Health CareSub-Industry: Health Care Supplies
Country: United Kingdom

About Haleon PLC

Company Description

We are a world-leading consumer health companywith a clear purpose to deliver better everyday health with humanity.

Our leading brands are built on science, innovation and human understanding and are trusted by millions of consumers globally. Haleon has a strong portfolio of brands and is well positioned to play a vital role for people all around the world, in a sector that is growing and more relevant than ever.

The definition of consumer healthcare varies across competitors and industry data sources. We define it as consisting of Oral Health, VMS and Over-the-Counter (OTC). Within OTC, Haleon's portfolio comprises of Pain, Respiratory, Digestive and Other.

Year founded

2022

Served area

Worldwide

Headcount

24,622

Headquarters

Building 5, First Floor, The Heights, KT13 0NY Weybridge – United Kingdom

Financial statements

Download as Excel
Line item in (gbp) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Assets N/A N/A 34,451,000,000.00 34,815,000,000.00
Noncurrent Assets N/A N/A 29,200,000,000.00 30,756,000,000.00
Property Plant And Equipment N/A N/A 1,563,000,000.00 1,757,000,000.00
Deferred Tax Assets N/A N/A 312,000,000.00 220,000,000.00
Noncurrent Recognised Assets Defined Benefit Plan N/A N/A 11,000,000.00 25,000,000.00
Noncurrent Derivative Financial Assets N/A N/A 12,000,000.00 44,000,000.00
Other Noncurrent Assets N/A N/A 8,000,000.00 132,000,000.00
Current Assets N/A N/A 5,251,000,000.00 4,059,000,000.00
Inventories N/A N/A 951,000,000.00 1,348,000,000.00
Trade And Other Current Receivables N/A N/A 2,207,000,000.00 1,881,000,000.00
Current Tax Assets Current N/A N/A 166,000,000.00 96,000,000.00
Cash and cash equivalents N/A 333,000,000.00 414,000,000.00 684,000,000.00
Current Derivative Financial Assets N/A N/A 5,000,000.00 50,000,000.00
Equity 27,412,000,000.00 26,223,000,000.00 26,480,000,000.00 16,457,000,000.00
Issued Capital N/A N/A 1,000,000.00 92,000,000.00
Retained Earnings N/A N/A 37,538,000,000.00 26,730,000,000.00
Share Premium N/A N/A 0.00 0.00
Other Reserves N/A N/A -11,632,000,000.00 -11,537,000,000.00
Equity Attributable To Owners Of Parent N/A N/A 26,355,000,000.00 16,331,000,000.00
Noncontrolling Interests N/A N/A 125,000,000.00 126,000,000.00
Liabilities N/A N/A 7,971,000,000.00 18,358,000,000.00
Noncurrent Liabilities N/A N/A 3,733,000,000.00 13,988,000,000.00
Noncurrent Provisions N/A N/A 27,000,000.00 26,000,000.00
Deferred Tax Liabilities N/A N/A 3,357,000,000.00 3,601,000,000.00
Noncurrent Recognised Liabilities Defined Benefit Plan N/A N/A 253,000,000.00 161,000,000.00
Noncurrent Derivative Financial Liabilities N/A N/A 1,000,000.00 175,000,000.00
Other Noncurrent Liabilities N/A N/A 8,000,000.00 22,000,000.00
Longterm Borrowings N/A N/A 87,000,000.00 10,003,000,000.00
Current Liabilities N/A N/A 4,238,000,000.00 4,370,000,000.00
Current Provisions N/A N/A 112,000,000.00 71,000,000.00
Trade And Other Current Payables N/A N/A 3,002,000,000.00 3,621,000,000.00
Current Tax Liabilities Current N/A N/A 202,000,000.00 210,000,000.00
Current Derivative Financial Liabilities N/A N/A 18,000,000.00 31,000,000.00
Current Borrowings And Current Portion Of Noncurrent Borrowings N/A N/A 79,000,000.00 437,000,000.00
Line item in (gbp) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 9,892,000,000.00 9,545,000,000.00 10,858,000,000.00
Profit Loss From Operating Activities 1,598,000,000.00 1,638,000,000.00 1,825,000,000.00
Finance Income 20,000,000.00 17,000,000.00 51,000,000.00
Finance Costs 27,000,000.00 19,000,000.00 258,000,000.00
Profit Loss Before Tax 1,591,000,000.00 1,636,000,000.00 1,618,000,000.00
Income Tax Expense Continuing Operations 410,000,000.00 197,000,000.00 499,000,000.00
Profit (loss) 1,181,000,000.00 1,439,000,000.00 1,119,000,000.00
Profit Loss Attributable To Owners Of Parent 1,145,000,000.00 1,390,000,000.00 1,060,000,000.00
Profit Loss Attributable To Noncontrolling Interests 36,000,000.00 49,000,000.00 59,000,000.00
Line item in (gbp) 01.01.2021 01.01.2022 01.01.2023
Profit (loss) 1,181,000,000.00 1,439,000,000.00 1,119,000,000.00
Adjustments For Income Tax Expense 410,000,000.00 197,000,000.00 499,000,000.00
Adjustments For Decrease Increase In Inventories 130,000,000.00 -17,000,000.00 -292,000,000.00
Adjustments For Increase Decrease In Trade Account Payable 140,000,000.00 41,000,000.00 387,000,000.00
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss 88,000,000.00 1,000,000.00 143,000,000.00
Adjustments For Provisions -27,000,000.00 -36,000,000.00 -43,000,000.00
Adjustments For Fair Value Gains Losses 91,000,000.00 0.00 0.00
Other Adjustments For Noncash Items 100,000,000.00 -22,000,000.00 24,000,000.00
Adjustments For Losses Gains On Disposal Of Noncurrent Assets 209,000,000.00 31,000,000.00 30,000,000.00
Income Taxes Paid Refund Classified As Operating Activities 554,000,000.00 310,000,000.00 324,000,000.00
Cash Flows From Used In Operating Activities 1,407,000,000.00 1,356,000,000.00 2,063,000,000.00
Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities 221,000,000.00 0.00 0.00
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities -20,000,000.00 0.00 0.00
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities 6,000,000.00 12,000,000.00 0.00
Purchase Of Property Plant And Equipment Classified As Investing Activities 222,000,000.00 228,000,000.00 304,000,000.00
Proceeds From Sales Of Intangible Assets Classified As Investing Activities 924,000,000.00 137,000,000.00 36,000,000.00
Purchase Of Intangible Assets Classified As Investing Activities 96,000,000.00 70,000,000.00 24,000,000.00
Interest Received Classified As Investing Activities 19,000,000.00 16,000,000.00 19,000,000.00
Cash Flows From Used In Investing Activities 1,030,000,000.00 -33,000,000.00 -8,784,000,000.00
Proceeds From Borrowings Classified As Financing Activities 38,000,000.00 8,000,000.00 11,004,000,000.00
Repayments Of Borrowings Classified As Financing Activities 10,000,000.00 0.00 1,518,000,000.00
Payments Of Lease Liabilities Classified As Financing Activities 44,000,000.00 38,000,000.00 45,000,000.00
Interest Paid Classified As Financing Activities 19,000,000.00 15,000,000.00 163,000,000.00
Other Inflows Outflows Of Cash Classified As Financing Activities 0.00 -12,000,000.00 345,000,000.00
Cash Flows From Used In Financing Activities -2,437,000,000.00 -1,236,000,000.00 6,911,000,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents -6,000,000.00 -4,000,000.00 15,000,000.00
Cash and cash equivalents 333,000,000.00 414,000,000.00 684,000,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Short Interest


Current short interest

Position Holder Short Interest in Percent Date
Marshall Wace LLP 0.50% 21.05.24
Marshall Wace LLP 0.52% 02.05.24
Total 1.02%

Capital markets information

ISIN

GB00BMX86B70

LEI

549300PSB3WWEODCUP19

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Supplies

Listed Stock Exchange

London Stock Exchange

Stock Index

FTSE 100

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.